Build Capital Partners

Build Capital Partners is a hybrid private equity and venture firm based in Salt Lake City that backs high-growth healthcare companies, with an explicit focus on infusion therapy and adjacent care delivery models. The portfolio includes Pure Healthcare, which signals direct experience in the home and ambulatory infusion space. AI is not the focus; this is a services and operations-driven fund where the edge comes from understanding the regulatory, payer, and operational mechanics of specialty care delivery.

The firm invests at the growth stage with check sizes of $5M to $25M. That positions it as a meaningful capital partner for healthcare services companies past the earliest-risk window, with revenue and a defined expansion plan. It is unlikely to lead pre-revenue venture rounds.

Founders should approach Build Capital Partners when they are building a tech-enabled healthcare services business — infusion, specialty pharmacy, ambulatory care delivery — with traction, defensible payer relationships, and a clear plan for geographic or service-line expansion. Devices, biotech, and pure software companies without a services component are not the right fit. The hybrid PE/venture structure means the firm is flexible on transaction shape, but expect operational diligence focused on payer contracting, clinical staffing, and reimbursement risk. Founders should arrive with a clean operations story, evidence of margin durability, and a thesis on how Build’s capital and PE-style support accelerate a specific consolidation or scaling plan rather than fund product development.